Carregant...
Large-Scale Analysis Reveals Gene Signature for Survival Prediction in Primary Glioblastoma
Glioblastoma multiforme (GBM) is the most aggressive and common primary central nervous system tumour. Despite extensive therapy, GBM patients usually have poor prognosis with a median survival of 12–15 months. Novel molecular biomarkers that can improve survival prediction and help with treatment s...
Guardat en:
| Publicat a: | Mol Neurobiol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer US
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7541357/ https://ncbi.nlm.nih.gov/pubmed/32875483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12035-020-02088-w |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|